Dr. Musaddiq J. Awan
Claim this profileMedical College of Wisconsin
Studies Squamous Cell Carcinoma
Studies Head and Neck Cancers
4 reported clinical trials
13 drugs studied
Area of expertise
1Squamous Cell Carcinoma
HPV negative
p16 negative
EGFR positive
2Head And Neck Cancers
Stage IV
HPV negative
Affiliated Hospitals
Clinical Trials Musaddiq J. Awan is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Reduced-Dose Radiotherapy
for Head and Neck Cancer
This trial is testing a new radiation treatment for patients with head and neck cancer after surgery. The goal is to see if this method is as safe and effective as the traditional longer course of treatment.
Recruiting1 award N/A
More about Musaddiq J. Awan
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Musaddiq J. Awan has experience with
- Atezolizumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- 50 Gy Radiation Therapy
- 55 Gy Radiation Therapy
- 60 Gy Radiation Therapy
Breakdown of trials Musaddiq J. Awan has run
Squamous Cell Carcinoma
Head and Neck Cancers
Cancer
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Musaddiq J. Awan specialize in?
Musaddiq J. Awan focuses on Squamous Cell Carcinoma and Head and Neck Cancers. In particular, much of their work with Squamous Cell Carcinoma has involved HPV negative patients, or patients who are p16 negative.
Is Musaddiq J. Awan currently recruiting for clinical trials?
Yes, Musaddiq J. Awan is currently recruiting for 2 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Musaddiq J. Awan has studied deeply?
Yes, Musaddiq J. Awan has studied treatments such as Atezolizumab, Cisplatin, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Musaddiq J. Awan?
Apply for one of the trials that Musaddiq J. Awan is conducting.
What is the office address of Musaddiq J. Awan?
The office of Musaddiq J. Awan is located at: Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.